Bioxytran, Inc.
Bioxytran, Inc. (BIXT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIXT · as of Jun 9, 2026
Key Statistics
Explore Bioxytran, Inc. Data
bixt stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bixt competitorsBIXT
BETRF
BVAXF
BZYR
CPMV
GLWLFStock Performance
Full HistoryAbout Bioxytran, Inc.
Bioxytran, Inc. is a pharmaceutical firm operating in the clinical development phase, dedicated to creating, producing, and marketing medicinal treatments for oxygen deficiency (hypoxia) in people. It…
what is bioxytran, inc. · bixt stock overview · bioxytran, inc. company profile · who is bioxytran, inc. ceo · bixt OTC · bioxytran, inc. headquarters · bioxytran, inc. business segments
About Stock Overview & Key Data
Bioxytran, Inc. (BIXT) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 5, 2010. As of the latest trading session, BIXT stock price is $0.03, with a market capitalization of $3.4M. The stock has returned -76.47% over the past 12 months and -60.16% year-to-date.
In fiscal year 2025, Bioxytran, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bioxytran, Inc. (BIXT) stock price is $0.03. The stock is traded on OTC under the ticker symbol BIXT. The 52-week range is $0.03 – $0.14.